This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Janet Sarah Smith: Innovator in Pharmaceutical Formulations
Introduction
Janet Sarah Smith is a notable inventor based in Sandwich, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled-release formulations. Her work is recognized for its potential impact on the treatment of benign prostatic hyperplasia (BPH).
Latest Patents
Janet holds 1 patent for her invention titled "Pharmaceutical formulations." This invention provides a controlled-release pharmaceutical formulation for oral administration, which includes a specific compound known as 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline, or a pharmaceutically acceptable salt thereof. The formulation is designed to release at least 50% by weight of the active ingredient after 6 hours under specified conditions, making it suitable for treating BPH.
Career Highlights
Janet is currently associated with Pfizer Corporation, a leading global pharmaceutical company. Her role involves research and development in innovative drug formulations, contributing to advancements in medical treatments.
Collaborations
Throughout her career, Janet has collaborated with esteemed colleagues, including John Douglas Davis and Michael John Humphrey. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Janet Sarah Smith's contributions to pharmaceutical formulations exemplify the importance of innovation in healthcare. Her work not only advances medical science but also improves patient outcomes.